Navigation Links
The Pharmaceutical Market: UK
Date:5/29/2012

NEW YORK, May 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Pharmaceutical Market: UK

http://www.reportlinker.com/p0203096/The-Pharmaceutical-Market-UK.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series. A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

TABLE OF CONTENTS EXECUTIVE SUMMARY 1

Snapshot: Strategic Espicom Analysis 2

Snapshot: Key Data Projections3

MACROENVIRONMENT 4

POLITICAL 4

ECONOMIC5

Projections 5

LEGAL6

EU Patent Protection & Intellectual Property Rights 6

Proposal for Unitary Patent 6

EU Supplementary Protection Certificates6

EU Data Exclusivity6

DEMOGRAPHIC 7

Projections 7

Demographic Indicators8

Births 8

Deaths 8

Infant Deaths 8

Life Expectancy at Birth 8

EPIDEMIOLOGY 9

DISEASE BURDEN 9

Leading Causes of Mortality9

DISEASE PREVALENCE10

Communicable Diseases 10

HIV/AIDS 10

Non-Communicable Diseases 11

Cancer 11

Diabetes 11

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 12

EU DIRECTIVE12

Cross-Border Healthcare Directive 12

ORGANISATION 12

Performance 12

Structure 13

Department of Health 14

Strategic Health Authorities 14

Primary Care Trusts 14

Acute Trusts 14

NHS Foundation Trusts 14

NHS Care Trusts 15

Ambulance Trusts 15

Care Quality Commission 15

EXPENDITURE 17

Projections 17

NHS Budget 18

Private Healthcare 18

INFRASTRUCTURE 19

Hospital Infrastructure19

Private Hospital Operators19

BMI Healthcare 19

HCA International 19

Netcare 19

NHS Trusts 20

Nuffield Health 20

Partnership Health Group (PHG) 20

Ramsay Healthcare20

Spire Healthcare 20

Ambulatory Infrastructure21

SERVICES 21

Hospital Inpatient Services 21

Outpatient Services22

WORKFORCE 22

Projections 22

Physicians 23

Nurses 23

Dentists 24

Pharmacists 24

REGULATORY AFFAIRS 25

EU REGULATORY AUTHORITY 25

NATIONAL AUTHORITIES 25

MARKETING REGISTRATION 26

EU Marketing Registration26

Centralised Procedure 26

National Procedures 27

IMPORT REGULATIONS 27

Parallel Trade 27

PROMOTION 28

Advertising 28

PRICING & REIMBURSEMENT 29

EU NETWORKING MEETING 29

NM CAPR29

PRICING 29

PPRS Reforms 29

Patient Access Schemes 30

Prescription Charges 31

REIMBURSEMENT 31

DISTRIBUTION CHANNELS 34

EU DIRECTIVE 34

Falsified Medicines Directive34

DRUG WHOLESALING 34

Association of Wholesalers 34

BAPW34

Leading Wholesalers 35

AAH Pharmaceuticals 35

Alliance Healthcare35

DRUG RETAILING 36

Association of Independent Pharmacies 36

Numark36

Association of Community Pharmacies36

NPA 36

Leading Pharmacy Chains 37

Alliance Boots 37

Lloydspharmacy 37

Superdrug 37

MARKET ANALYSIS 38

SIZE 38

Projections 38

Historical Figures 40

Current Structure 41

PRODUCT DEVELOPMENT 49

EU Programmes49

Horizon 2020 49

IMI 49

National Research & Development 49

MANUFACTURING 52

TRADE53

Exports 53

Imports 56

Balance of Trade 60

COMPETITION 61

TRADE ASSOCIATIONS 61

ABPI 61

COMPANY INTELLIGENCE 62

AstraZeneca62

Eisai62

Eli Lilly 62

GlaxoSmithKline 62

MSD63

Novartis 63

Pfizer 64

ProStrakan64

Shire Pharmaceuticals 65

ViiV Healthcare 65

Competitive Strategies65

GLOBAL COMPANY INTELLIGENCE 66

AstraZeneca66

Company Overview 66

Financial Performance66

Product Portfolio 67

R&D Strategy 69

Manufacturing Capabilities 71

Outlook 71

GlaxoSmithKline 72

Company Overview 72

Financial Performance72

Product Portfolio 73

R&D Strategy 75

Manufacturing Capabilities 76

Outlook 76

Shire 77

Company Overview 77

Financial Performance78

Product Portfolio 79

R&D Strategy 80

Manufacturing Capabilities 81

OTC PHARMACEUTICALS 82

REGULATION 82

Marketing Registration 82

Labelling 82

MARKET SIZE 83

COMPETITION 84

Trade Association84

PAGB 84

GENERIC PHARMACEUTICALS 85

REGULATION 85

EU Marketing Registration85

Pricing & Reimbursement 85

Generic Substitution Plans are Scrapped 85

Unbranded Generic Pricing 85

2005 Generics Reimbursement Scheme 86

MARKET SIZE 87

COMPETITION 90

Trade Association90

BGMA90

Company Intelligence 90

Actavis 90

Bristol Laboratories90

Dr Reddy's 91

Kent Pharmaceuticals 91

Pfizer 91

Rosemont Pharmaceuticals 91

Teva Pharmaceuticals 91

Winthrop Pharmaceuticals 92

Wockhardt 92

BIOLOGICS & BIOSIMILARS 93

REGULATION 93

EU Approval Process 93

EU Regulation of Biosimilars 93

EMA Guideline Documents94

Draft Biosimilar Concept Paper94

Biosimilar mAb Guideline 94

Biosimilars Approved in the EU 95

National Regulation 95

NICE Approves First Biosimilar for NHS Use95

PRODUCT DEVELOPMENT 96

Cancer Research 96

Stem Cell Research 96

COMPETITION 97

Trade Association97

BIA 97

Company Intelligence 97

Angel Biotechnology97

Argenta 97

Ark Therapeutics 98

Astex Therapeutics98

BigDNA98

BioFocus 98

Biogen Idec 98

BTG 99

Cellartis99

Convergence Pharmaceuticals 99

FMC BioPolymer 99

ImmuPharma 99

Intercell 99

Lonza 100

NovaBiotics100

Oxford BioMedica100

PolyTherics 100

Silence Therapeutics 101

UCB 101

Competitive Strategies 101

CONCLUSIONS: OPPORTUNITIES & CHALLENGES 103

Strategic Espicom Analysis 103

MACROENVIRONMENT 103

EPIDEMIOLOGY 103

HEALTHCARE103

REGULATORY AFFAIRS104

PRICING & REIMBURSEMENT 104

DISTRIBUTION CHANNELS 105

MARKET 105

COMPETITION 106

OTC PHARMACEUTICALS 106

GENERIC PHARMACEUTICALS106

BIOLOGICS & BIOSIMILARS 106

Radar Analysis 108

SWOT Analysis 108

DIRECTORY 109

GOVERNMENT ORGANISATIONS 109

PHARMACEUTICAL COMPANIES 109

Biologic Companies 109

Generic Companies 109

PHARMACEUTICAL DISTRIBUTORS110

PHARMACY CHAINS 110

TRADE ORGANISATIONS110

List of Tables

Espicom Analysis of the Pharmaceutical Market, 2012 2Key Data Projections, 2012-2017 3Political Landscape, 2012 4Regional Ranking of Projected Economies, 2017 5Projected Economy, 2012-2017 5Regional Ranking of Projected Demographics, 2017 7Projected Demographics, 2012-2017 7Demographic Indicators, 2002-2009 8Causes of Death by Country, 2010 9HIV and AIDS Cases, up to 2010 10Regional Ranking of Projected Health Expenditure, 2017 17Projected Health Expenditure, 2012-201717Inpatient Procedures and Interventions by Type, 2010/11 21Regional Ranking of Projected Physicians, 2017 22Projected Physicians, 2012-2017 22Consultants by Specialty in England, 2008-2010 23NHS Nurses by Country, 2007-2009 23Patient Access Schemes in Published Guidance, 2007-2010 30NICE Appraisals in Development, January 2012 31Members of BAPW, 2011 34Celesio's Revenue from Wholesale Activities, 2007-2009 (Euro Millions) 35Alliance Healthcare's Financial Highlights, 2008-2010 (£ Millions) 35Regional Ranking of Projected Pharmaceutical Markets, 2017 38Projected Pharmaceutical Market at Retail Prices, 2012-2017 38Historical Pharmaceutical Market at Retail Prices, 1995-2011 40Written Prescriptions, 2006-2010 (Millions) 41Prescriptions by Value, 2006-2010 (£ Millions) 41Prescriptions & Cost by Therapeutic Area in the UK, 2010 42Prescriptions & Cost by Therapeutic Area in England, 2010 43Top 20 Prescribed Drugs in England by Value, 2010 44Top 20 Prescribed Drugs in England by Volume, 2010 45Cost of Pharmaceuticals Issued by Hospital Pharmacies in England, 2003-2010 (£ Millions) 45Prescriptions & Cost by Therapeutic Area in Wales, 2010 46Prescriptions & Cost by Therapeutic Area in Scotland, 2010 47Prescriptions & Cost by Therapeutic Area in Northern Ireland, 201048Pharmaceutical R&D Expenditure, 1972-2007 (£ Millions) 50Pharmaceutical Production, 1995-2010 (Euros 000s) 52Pharmaceutical Exports by Category, 1995-2010 (US$000s) 53Pharmaceutical Exports by Country/Region, 2010 (US$000s) 55Pharmaceutical Imports by Category, 1995-2010 (US$000s) 56Imports of Raw Materials by Country/Region, 2010 (US$000s) 58Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 58Imports of Medicaments by Country/Region, 2010 (US$000s) 59Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 60Full Members of the ABPI, 2011 61AstraZeneca's Principal Operating Results, 2006-2010 (US$ Million) 66AstraZeneca's Sales by Geographic Area, 2006-2010 (US$ Million) 67AstraZeneca's Sales by Leading Products, 2006-2010 (US$ Million)68AstraZeneca's Recent Product Approvals, 2010-2011 69AstraZeneca's Major Manufacturing Facilities by Location, 2011 71GSK's Principal Operating Results, 2006-2010 (£ Million) 73GSK's Sales by Geographic Area, 2007-2010 (£ Million) 73GSK's Sales by Leading Products, 2006-2010 (£ Million) 74GSK's Recent Product Approvals, 2010-2011 75 Shire's Principal Operating Results, 2006-2010 (US$ Million) 78Shire's Revenue by Business Area, 2006-2010 (US$ Million) 78Shire's Revenue by Geographic Area, 2006-2010 (US$ Million) 78Shire's Revenue by Leading Products, 2006-2010 (US$ Million) 79Shire's Recent Product Approvals, 2010-2011 80Shire's Major Manufacturing Facilities by Location, 2011 81OTC Sales at Retail Prices, 2007-2010 (£ Millions) 83Full Members of PAGB, 2011 84Prescriptions Written and Dispensed Generically in England by Value, 1996-2010 (£ Millions) 87Prescriptions Written and Dispensed Generically in England by Volume, 1996-2010 (Millions) 88Generic Prescribing Rates by Therapeutic Area in England, 2005-2010 (% by Volume) 88Generic Dispensing Rates by Therapeutic Area in England, 2005-2010 (% by Volume) 89Members of BGMA, 2011 90Biosimilars Approved in the EU 95Espicom Analysis of the Pharmaceutical Market, 2012 107SWOT Analysis of the Pharmaceutical Market, 2012 108

List of Charts

Regional Comparison of Top 5 Projected Pharmaceutical Markets at Retail Prices, 2017 39

Regional Comparison of Projected Pharmaceutical Market Share, 2017 39

Historical Pharmaceutical Market at Retail Prices, 1995-201140

Pharmaceutical Exports, 1995-2010 (US$ Billions) 54

Pharmaceutical Exports by Country/Region, 2010 (%) 54

Pharmaceutical Imports, 1995-2010 (US$ Billions) 56

Imports of Pharmaceuticals by Country/Region, 2010 (%) 57

Balance of Pharmaceutical Trade, 1995-2010 (US$ Billions)60

Radar Graph of the Pharmaceutical Market, 2012 108

To order this report:Pharmaceutical Industry: The Pharmaceutical Market: UK

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

 


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Pharmaceutical Market: India
2. The Pharmaceutical Market: USA
3. K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity
4. Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting
5. Pharmaceuticals - Global Group of Eight (G8) Industry Guide
6. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
7. New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments
8. Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting
9. Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
10. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
11. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... CITY, Mo. , May 3, 2016 /PRNewswire/ ... Kansas Medical Center,s Institute for Advancing Medical Innovation ... and commercialize new drugs, diagnostics and medical devices. ... provides BioNovus Innovations with rights to license, develop ... "This partnership represents ...
(Date:5/3/2016)... LAKE OSWEGO, Ore. , May 3, 2016 ... and endovascular medical technology, today announced Food and ... a cardiac resynchronization defibrillator that provides heart failure ... (MRI) scans. Iperia devices also have remote monitoring ... (CLS) that adapts the heart rate in response ...
(Date:5/3/2016)... , May 3, 2016 ... Market Size, Share, Development, Growth and Demand Forecast to ... by Field Strength (High Field, Very High Field, Low ... (Brain, Head and Neck, Spine, Musculoskeletal, Vascular, Breast, Pelvic ... global magnetic resonance imaging (MRI) market was valued at ...
Breaking Medicine Technology:
(Date:5/5/2016)... , ... May 05, 2016 , ... Derrin Doty Group ... families of Bremerton, Port Orchard and communities west of Seattle. The insurance provider’s caring ... year local girl who died suddenly due to complications from the flu, that they ...
(Date:5/5/2016)... ... May 05, 2016 , ... A recent survey by the Midwest ... getting employees to understand and use the free preventive care benefits available to them ... business groups of large, self-insured public and private employers, MBGH found that only 10% ...
(Date:5/5/2016)... ... May 05, 2016 , ... Standard ... veterinary professionals across the United States. The whole food nutrient solutions company can ... and giving dog, cat and horse owners’ peace of mind. With the increased ...
(Date:5/5/2016)... ... May 05, 2016 , ... The 2016 Nike Soccer Camp ... along with his university coaching staff. Together they bring their winning Vandals coaching philosophy ... for youth players ages 5-13, and high school players. Session dates are as follows: ...
(Date:5/5/2016)... ... 05, 2016 , ... Chronic stress can have a silent, yet dangerous, impact ... immune system and increase inflammation, both of which raise the risk of heart attack ... disease program at Harvard-affiliated Massachusetts General Hospital. Chronic stress also can lead to other ...
Breaking Medicine News(10 mins):